U.S. to purchase 1.4 mln extra programs of Merck’s COVID-19 capsule – ET HealthWorld

Merck & Co Inc and companion Ridgeback Biotherapeutics mentioned on Tuesday the U.S. authorities would purchase a further 1.4 million programs of their COVID-19 capsule, molnupiravir.

The U.S. authorities in June agreed to spend $1.2 billion for 1.7 million programs.

The federal government is now exercising choices to purchase the additional doses, valuing the contract at $2.2 billion for a complete of three.1 million programs, the businesses mentioned.

The U.S. authorities additionally has choices to buy greater than 2 million further programs below the contract, they added.

Observe and join with us on , Fb, Linkedin

Supply hyperlink

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top